Search Results
Remaining questions surrounding HER2-low breast cancer – how low can you go?
Remaining questions on the management of HER2-low breast cancer
Remaining challenges regarding HER2-low breast cancer
Overview of the management of HER2-low breast cancer patients
Is HER2-low a distinct subtype of breast cancer?
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis
The comprehensive genomic characterization of HER2-low breast cancer
Highlights in HER2-low breast cancer at SABCS 2022
HER2-Positive Biliary Tract Cancer: New Developments and Future Directions
Biological behaviour of HER2-low BC is dependent on HR expression
HER2-Low Breast Cancer: DESTINY or Good Science?
The Science of HER2-low Breast Cancer and Implications for the Pathology Team
